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Introduction
============

Obsessive-compulsive disorder (OCD) is a psychiatric disorder with an estimated lifetime prevalence of 2% in the general population ([@awaa100-B55]; [@awaa100-B27]). The main symptoms are anxiety, obsessive thoughts (obsessions) and repetitive behaviours (compulsions). Patients are commonly treated with cognitive behavioural therapy and/or selective serotonin reuptake inhibitors ([@awaa100-B16]). Treatment for patients who do not respond sufficiently includes clomipramine and a combination of SSRIs with antipsychotics. Approximately 10% of patients with OCD remain treatment refractory and continue to experience symptoms despite pharmacological and behavioural treatment ([@awaa100-B16]). For those patients, deep brain stimulation (DBS) is an emerging treatment option with a ∼60% responder rate ([@awaa100-B2]).

In DBS, electrodes are implanted in brain regions that can then be selectively and focally stimulated with electrical impulses. DBS has been tested as a viable treatment option in several psychiatric conditions such as depression, anorexia nervosa and addiction ([@awaa100-B44]; [@awaa100-B43]). In OCD, the most common target regions include striatal regions such as nucleus accumbens (NAc), ventral capsule/ventral striatum and ventral anterior limb of the internal capsule (vALIC). Other common regions are subthalamic nucleus, inferior thalamic peduncle and more recently, medial forebrain bundle ([@awaa100-B15]; [@awaa100-B10]). Once stimulation parameters have been optimized, DBS of the vALIC results in a typical sequence of symptom improvements. Patients initially experience rapid improvements of mood and anxiety, followed by more gradual decrease of obsessions and compulsion, which may take several weeks and often require additional behavioural therapy for several months ([@awaa100-B17]; [@awaa100-B46]). We found that decreased obsessions and compulsions following DBS were associated with normalization of frontostriatal network function ([@awaa100-B21]). However, it remains puzzling how vALIC DBS induces its rapid changes in mood and anxiety.

Here we investigated whether rapid mood and anxiety effects of vALIC-DBS are due to modulation of circuits involving a predominant role of the amygdala. The amygdalae are crucial for the detection of salient events and the initiation of anxiety ([@awaa100-B13]). Mood and anxiety disorders have been consistently associated with increased activity of amygdala and insula, and decreased activity of the prefrontal cortex ([@awaa100-B20]; [@awaa100-B32]; [@awaa100-B59]; [@awaa100-B66]; [@awaa100-B61]). Functional connectivity between amygdala and insula is positively correlated to anxiety ([@awaa100-B6]), whereas functional connectivity between amygdala and ventromedial prefrontal cortex (vmPFC) is negatively correlated to anxiety and negative affect ([@awaa100-B39]; [@awaa100-B49]). The vALIC DBS target region is strongly connected with the amygdala, insula, and vmPFC ([@awaa100-B8]). We therefore hypothesized that rapid mood and anxiety effects of vALIC DBS result from modulation in connectivity between the amygdala, insula and vmPFC.

In this study, we used two methods to assess changes in connectivity as measured with resting state functional MRI. First, we used functional connectivity to measure correlations in spontaneous slow fluctuations (\<0.1 Hz) in blood oxygen level-dependent signals between the amygdala and the rest of the brain. This method has shown considerable intra-subject reproducibility ([@awaa100-B58]; [@awaa100-B67]) and has been linked to behavioural variability ([@awaa100-B9]). Because the amygdala is composed of distinct nuclei that have different roles in affect regulation ([@awaa100-B36]), we further assessed the independent role of the centromedial and laterobasal amygdala groups. Second, we used effective connectivity as a measure of directed or causal connectivity between areas ([@awaa100-B24]) to assess the influence of the amygdala, insula and vmPFC on one another. We also included the NAc in this model because (i) DBS was targeted at the border of the NAc and vALIC; (ii) the NAc is strongly connected with the amygdala, insula, and vmPFC ([@awaa100-B8]); and (iii) we previously observed DBS-related changes in NAc connectivity ([@awaa100-B21]). We used spectral dynamic causal modelling (DCM) ([@awaa100-B26]; [@awaa100-B53]), which is particularly suited to measure group differences in effective connectivity during the resting state. It is based on constructing a biologically plausible model that generates a predicted response in the frequency domain and fitting that to the observed response. This enables one to infer causal influences one region exerts over another. DCM provides estimation of parameters that give information on the strength of those causal influences between regions of interest, referred to as effective connectivity ([@awaa100-B25], [@awaa100-B26]). To test the influence of DBS on these parameters, patients were investigated twice. The first resting state scan was obtained after DBS treatment for at least a year (DBS on), and the second resting state scan was obtained when stimulation was turned off for 1 week (DBS off). To control for test-retest effects on the connectivity measures, a group of healthy controls was also measured twice. Based on the positive association between anxiety and amygdala-insula connectivity and the negative association between amygdala-vmPFC connectivity, we hypothesized that the effect of DBS treatment on mood and anxiety could either be explained by decreased amygdala-insula connectivity, increased amygdala-vmPFC connectivity, or both.

Materials and methods
=====================

Participants
------------

Sixteen patients with treatment refractory OCD were recruited from the outpatient clinic for DBS at the Department of Psychiatry of the Academic Medical Center in Amsterdam, the Netherlands. Symptom severity was assessed using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) ([@awaa100-B29], [@awaa100-B28]), the Hamilton Depression Rating Scale (HAM-D) ([@awaa100-B34]) and the Hamilton Anxiety Rating Scale (HAM-A) ([@awaa100-B33]). Two quadripolar electrodes (Model 3389; Medtronics Inc.) with four contact points of 1.5 mm long and intersected by 0.5 mm spaces were implanted bilaterally through the anterior limb of the internal capsule with the deepest contact point located in the NAc in the plane 3 mm anterior to the anterior commissure and the three upper contact points positioned in the vALIC. Patients were included only if they had undergone an optimization phase of at least 1 year. During this phase, patients were evaluated every 2 weeks and stimulation parameters were adjusted in order to obtain the optimal clinical response. For all patients the optimal stimulation was monopolar using the two middle contact points superior to the NAc, in the vALIC. We could not collect all resting state functional MRI data for three patients, one patient had a deviating electrode placement, and data from two patients were excluded due to excessive head motion during scanning (max movement \> 2.5 mm or 2.5 degrees of rotation), leaving a final sample for data analysis of 10 patients. At the commencement of the study the mean stimulation voltage was 4.8 V (3.5--6.2 V), frequency was 130 Hz (nine patients) or 185 Hz (one patient). The pulse width was 90 μs (seven patients) or 150 μs (three patients). We recruited 16 healthy control participants from the community via local advertisements. Exclusion criteria were the presence of a mental disorder according to DSM-IV (Diagnostic and Statistical Manual of Mental Disorders IV) as assessed with the Mini International Neuropsychiatric Inventory ([@awaa100-B57]; [@awaa100-B65]), a family history of psychiatric disease, a history of head trauma, any neurological or other medical disorders, a history of substance abuse, or a contraindication for MRI. Data from one session of one patient were missing and data of four controls were excluded because of excessive head motion during scanning, leaving a final sample size of 11 controls. During the two scanning days, the participants did not use cigarettes, caffeine or sedatives. The study was approved by the Medical Ethics Committee of the Academic Medical Center in Amsterdam and all participants signed an informed consent form before participation.

Study design
------------

Each subject underwent two resting state functional MRI scans. Subjects were instructed to keep their eyes open during the scan. The first scan (DBS on) was performed after DBS had been constantly turned on for at least 1 year. After the first scan, patients entered the DBS off phase, and the second scan was performed 1 week later (DBS off). Symptom severity was assessed on each scanning day through the use of Y-BOCS, HAM-D and HAM-A. The healthy controls were scanned with 1 week in-between sessions.

Image acquisition
-----------------

Data were acquired using a 1.5 T Siemens MAGNETOM Avanto scanner. A transmit receive head coil was used to minimize exposure of DBS electrodes to the pulsed radiofrequency field. The DBS was turned off 2 min prior to scanning and programmed at 0 V in bipolar mode. The subject's head was held in place with padding and straps. Specific absorption rate was limited to 0.1 W/kg. Structural images were acquired with 1 × 1 × 1 mm resolution using a 3D sagittal MPRAGE with repetition time of 1.9 s, echo time of 3.08 ms, flip angle of 8° and inversion time of 1.1 s. Functional MRI data were acquired with 2D echo-planar imaging with repetition time = 2000 ms, echo time = 30 ms, flip angle = 90°. Each scan consisted of 25 transverse slices of 4-mm thick with in plane voxel size of 3.6 × 3.6 mm and slice gap of 0.4 mm. The first 10 volumes were discarded to allow for magnetization stabilization and the subsequent 180 volumes were analysed.

Image preprocessing
-------------------

Image processing was carried out using Nipype, a pipeline tool for neuroimaging data processing ([@awaa100-B30]) and SPM12 (<http://www.fil.ion.ucl.ac.uk/spm>). The functional data were first realigned to correct for motion using rigid body realignment to the first functional image. Subjects exhibiting more than 2.5 mm movement in any direction were excluded, resulting in 10 patients and 11 controls. After motion correction the brain extracted structural data were coregistered to functional space. The structural data were normalized to MNI152 (Montreal Neurological Institute) space using SPM's unified segmentation approach ([@awaa100-B3]), which is robust to brain lesions ([@awaa100-B12]) to accommodate the signal dropout due to the DBS system. The resulting non-linear warps were then used to normalize the functional data, which were resampled into 2-mm isotropic voxels and subsequently smoothed using an 8-mm Gaussian kernel and bandpass filtered from 0.01 to 0.1 Hz.

Functional connectivity analysis
--------------------------------

Data from regions of interest were extracted using SPM's Anatomy toolbox ([@awaa100-B18]). For each amygdala, the centromedial and laterobasal subregions were extracted. The mean signal in the region of interest was computed from the unsmoothed but bandpass filtered functional data. For the subregions the mean signal was weighted with the probability at each voxel as was done previously ([@awaa100-B54]). This gives stronger weight to those voxels more probable to belong to each subregion. Noise correction followed the procedure described by [@awaa100-B50]. Principal components were extracted from the CSF and white matter signals. The CSF tissue mask from SPM's unified segmentation was confined to the ventricles using the ALVIN mask ([@awaa100-B38]) and including only voxels with a 99% probability or higher as being CSF. The white matter mask was confined to a 99% probability or higher and eroded to minimize the risk of capturing signals from the nearby grey matter regions. For the signal at each voxel the voxel mean was removed and the results divided by the voxel standard deviation. Singular value decomposition was then used to generate principal components. The components accounting for the 50% of variance from each tissue class were included in the nuisance regression as covariates along with the six motion parameters and derivatives (computed using backward differences). The motion parameters were bandpass filtered to prevent inadvertent reintroduction of nuisance-related variation into frequencies previously suppressed by bandpass filtering ([@awaa100-B31]). For each analysis, the other subregion from the same hemisphere was included in the nuisance regression. After nuisance covariates were regressed out, the region of interest signal was correlated with the remaining residuals from the whole brain. This provided a map of correlation coefficients that were then transformed to *z*-scores using Fisher's transformation.

The individual statistical maps were entered into a 2 × 2 flexible factorial design using GLM Flex (<http://mrtools.mgh.harvard.edu/>) with partitioned error terms for the within and between subject factors. The factors included were Group (patients versus controls) and Condition (DBS on versus off). All main effects and interactions were computed. Voxel-wise statistical tests were familywise error-corrected for multiple comparisons at the cluster level (*P \< *0.05) using a cluster forming threshold of *P = *0.001 ([@awaa100-B19]) using peak_nii (<https://www.nitrc.org/projects/peak_nii>) for the whole brain or the regions of interest. The insula was extracted from the automatic anatomical labelling atlas ([@awaa100-B63]) using wfu Pickatlas ([@awaa100-B45]) and the vmPFC was defined as a 10-mm sphere centred on (−1, 49, −5) MNI coordinates ([@awaa100-B23]). *Post hoc t*-tests were performed in the presence of significant interactions between factors. Data were extracted from the entire region of interest for brain regions that showed significant clusters for subsequent correlation analyses with clinical scores.

Dynamic causal modelling
------------------------

Because functional connectivity analyses do not provide information about the direction of connectivity, we subsequently performed an effective connectivity analysis using spectral DCM. First a general linear model was set up in SPM with cosine basis functions from 1/128 Hz to 0.1 Hz as effects of interest and the movement parameters, white matter and CSF signals as nuisance regressors. This way the resulting effects of interest contrast over the basis functions reveals the resting state fluctuations in that frequency range. For model simplicity only regions of interest from the left hemisphere were included since the functional connectivity results were with the left amygdala. We included the amygdala and insula as regions of interest but also the NAc and vmPFC, because all of these regions are anatomically connected ([@awaa100-B8]) and we previously showed that vALIC DBS also influences NAc vmPFC connectivity ([@awaa100-B21]). The left amygdala was specified based on an anatomical atlas using the SPM anatomy toolbox. The NAc was defined as the caudate nucleus from the automatic anatomical atlas ([@awaa100-B18]) below *z *=* *0 and excluding the signal dropout due to the DBS electrodes. The vmPFC region of interest was specified as a 10-mm sphere centred on (−1, 49, −5) MNI coordinates ([@awaa100-B23]). The left insula region of interest was specified as a 10-mm sphere centred on the peak value in the region of interest from the seed-based correlation analysis. When extracting the signal, the spheres were allowed to shift to the nearest local maxima according to the effects of interest contrast defined above, but within the 10-mm sphere. From each region of interest the first principal eigenvariate, corrected for confounds, was used to represent the region of interest.

A DCM model was constructed with the four regions of interest as nodes. Bilateral connections between all nodes were defined, resulting in 16 connections including each node's self-connection ([Fig. 1](#awaa100-F1){ref-type="fig"}). Then for each subject this full model was inverted using spectral DCM in SPM (DCM12 revision 6662). The resulting posterior probabilities of each subject's connection coefficients were then entered into a repeated measures mixed ANOVA in MATLAB and solved for significant interactions between DBS on and off in patients and controls.

![**The causal neural model for the effects of DBS.** (**A**) A graph model showing the fully connected model with four regions, the vmPFC, insula, amygdala, and NAc. In a fully connected model, each region is reciprocally connected and each region has a self-inhibitory connection. (**B**) Blood oxygen level-dependent time series data from regions of interest from one subject.](awaa100f1){#awaa100-F1}

Data availability
-----------------

The data that support the findings of this study are available from the corresponding author, upon reasonable request.

Results
=======

Deep brain stimulation effects on mood and anxiety
--------------------------------------------------

Demographics and clinical characteristics are summarized in [Table 1](#awaa100-T1){ref-type="table"}. All participants were right-handed. The patients and controls did not differ in age, sex ratio, years of education and head motion during functional MRI scanning (all *P *\>* *0.05; [Table 1](#awaa100-T1){ref-type="table"}). All patients had OCD as primary diagnosis, four patients had co-morbid major depressive disorder, one had co-morbid panic disorder, and three had co-morbid obsessive-compulsive personality disorder. In line with our previous report on the clinical outcome of DBS ([@awaa100-B17]), turning off DBS increased anxiety symptoms \[HAM-A; *t*(9) = 2.84, *P = *0.019, paired *t*-test\], increased mood symptoms \[HAM-D; *t*(9) = 3.31, *P = *0.009, paired *t*-test\], and increased obsessive-compulsive symptoms \[Y-BOCS; *t*(9) = 3.46, *P *=* *0.007\].

###### 

Demographics of the study sample and clinical scales

                                             Patients (*n = *10)                                Controls (*n = *11)  Difference                 
  ------------------------------------------ ------------------------------------------------- --------------------- ------------- ------------ ------------------------------------------------
  Age, years                                 44.1 (9.7)                                               27--56         44.7 (9.1)       25--56    0.88[^a^](#tblfn2){ref-type="table-fn"}
  Gender, % males                            50                                                                      63.6                       0.37[^b^](#tblfn3){ref-type="table-fn"}
  Education, years                           13.7 (1.56)                                              12--16         15.7 (4.07)      12--23    0.16[^a^](#tblfn2){ref-type="table-fn"}
  Smoking, % yes                             30                                                                      54.5                       0.76[^b^](#tblfn3){ref-type="table-fn"}
  Illness duration, years                    27.6 (13.4)                                               8--48                                    
  Motion, mm (mean framewise displacement)   0.26 (0.13)                                            0.09--0.55       0.21 (0.08)    0.09--0.36  0.16
  **Clinical scales patients**               **DBS off** [^d^](#tblfn5){ref-type="table-fn"}        **DBS on**                                  
  Y-BOCS total                               28.5 (6.3)                                               15--38         18.9 (7.7)       6--32     \<0.01[^c^](#tblfn4){ref-type="table-fn"}^,^\*
  Y-BOCS obsessions                          13.7 (3.3)                                                9--19         9.0 (4.1)        0--15     \<0.01[^c^](#tblfn4){ref-type="table-fn"}\*
  Y-BOCS compulsions                         14.8 (4.0)                                                6--20         9.9 (4.0)        6--18     \<0.05[^c^](#tblfn4){ref-type="table-fn"}^,^\*
  HAM-D                                      30 (9.2)                                                 13--40         16.7 (10.4)      0--30     \<0.01[^c^](#tblfn4){ref-type="table-fn"}^,^\*
  HAM-A                                      38.3 (11.3)                                              11--51         17.7 (9.2)       4--31     \<0.05[^c^](#tblfn4){ref-type="table-fn"}^,^\*

Significant (two-tailed).

^a^Independent sample *t*-test.

^b^Chi-square test.

^c^Paired *t*-test.

^d^After 1 week of DBS off.

Y-BOCS = Yale-Brown Obsessive-Compulsive Scale.

The impact of deep brain stimulation on functional connectivity of the amygdala
-------------------------------------------------------------------------------

Functional connectivity analysis showed a significant interaction between group (patients versus controls) and session (DBS on versus off) of the left laterobasal amygdala groups with the right insula \[*P = *0.014, MNI: (44, −2, 4), size: 248 mm^3^, familywise error-corrected; [Fig. 2\]](#awaa100-F2){ref-type="fig"}. Left amygdala functional connectivity with the right insula increased from DBS on to DBS off in OCD patients, whereas it decreased between sessions in controls. *Post hoc* tests showed that the interaction was primarily driven by an increase in laterobasal amygdala-insula connectivity when DBS was switched off in the patient groups (*P = *0.009). Further, connectivity tended to be higher in patients than controls when DBS was switched off (*P = *0.078), and was not significantly different when DBS was on (*P = *0.51).

![**The effects of DBS on functional connectivity of the laterobasal amygdala with the insula.** (**A**) The left laterobasal amygdala seed region. (**B**) The significant interaction cluster in the right insula. (**C**) Parameter estimates for the significant interaction cluster (for illustrative purposes). (**D**) Correlation between changes in laterobasal amygdala-insula connectivity and HAM-A scores in OCD patients. The blue dots are data from each patient while the red line is a fitted regression line. (**E**) Correlation between changes in laterobasal amygdala-insula connectivity and HAM-D scores in OCD patients. \**P \< *0.05.](awaa100f2){#awaa100-F2}

The DBS-induced change in connectivity was positively correlated to changes in anxiety (*r *=* *0.67, *P = *0.035) and mood (*r *=* *0.67, *P = *0.033), such that a larger DBS-related increase in laterobasal amygdala-insula connectivity was associated with higher increase in mood and anxiety symptoms. The correlation between DBS-induced changes in mood and anxiety symptoms was 0.9 (*P = *0.0004), precluding further partial correlations and suggesting that the influence of DBS on these symptoms cannot be dissociated.

Dynamic causal modelling for deep brain stimulation effects
-----------------------------------------------------------

Our analysis showed an interaction between group and session for the connection between the left vmPFC and left amygdala \[*P = *0.045, FDR (false discovery rate) corrected\], and between the left amygdala and left insula (*P = *0.045, FDR corrected). The impact of the vmPFC over the amygdala was higher during DBS on compared to DBS off in patients (*P = *0.0122) and was higher during DBS on compared to controls (*P = *0.0012). The connection parameter for the impact of amygdala on insula was positive during DBS off, indicating an excitatory connection, whereas it was negative during DBS on, indicating an inhibitory connection (*P = *0.0052). Moreover, the connection parameter was lower in patients during DBS on compared to controls (*P = *0.033, [Fig. 3](#awaa100-F3){ref-type="fig"}).

![**The influence of DBS on effective connectivity between the amygdala, insula, vmPFC, and NAc.** (**A**) A graph model showing the fully connected model with four regions, the vmPFC, insula, amygdala, and NAc. In a fully connected model, each region is reciprocally connected and each region has a self-inhibitory connection. (**B**) The connection from vmPFC to the amygdala is higher when the DBS is on and is higher than in controls. (**C**) The connection from amygdala to insula reverses direction from inhibitory influence to excitatory when DBS is turned off. \**P \< *0.05, \*\**P \< *0.001.](awaa100f3){#awaa100-F3}

Discussion
==========

When undergoing vALIC DBS for OCD, the most prominent and rapid changes in symptoms are improvements in mood and anxiety. To understand the underlying mechanism, we investigated functional connectivity within the amygdala network and found that turning DBS off increased functional connectivity between amygdala and insula. This increase was correlated to an increase of both anxiety and mood symptoms. When analysing directional connectivity within the network, we found that during DBS the impact of vmPFC on amygdala was higher than when DBS was switched off and turning DBS off reversed the impact of amygdala on insula from inhibitory to excitatory.

This affective prefrontal-limbic network has primarily been linked to mood and anxiety disorders ([@awaa100-B20]; [@awaa100-B39]; [@awaa100-B32]; [@awaa100-B6]; [@awaa100-B61]), but it is also associated with OCD. In particular, OCD symptom-provoking stimuli induce exaggerated amygdala responses (v[@awaa100-B64]; [@awaa100-B60], [@awaa100-B59]). It has been suggested that elevated fear and anxiety, and associated frontolimbic impairments, may be causal to, or driving some of the compulsions ([@awaa100-B48]). This is supported by a recent meta-analysis ([@awaa100-B62]) that found increased activation of the amygdala during emotional processing in OCD, and that co-morbidity with mood and anxiety disorders was associated with even higher activations of the right amygdala, putamen and insula as well as lower activations in the left amygdala and right vmPFC. The insula is involved in perception of internal feelings ([@awaa100-B11]) and is suggested to have an important role in anxiety ([@awaa100-B51]). In OCD, the insula has been primarily associated with disgust sensitivity ([@awaa100-B56]), but animal studies suggest that it also has a crucial role in the development of compulsive behaviour ([@awaa100-B22080280]). Our results suggest that the effects of vALIC DBS on mood and anxiety are primarily driven by changes in connectivity between insula and amygdala, demonstrating the importance of these brain regions in OCD symptomatology.

Further, we showed that DBS alters the top-down control of vmPFC on amygdala and reverses amygdala drive on insula from excitatory to inhibitory. It has been shown that the strength of amygdala coupling with the vmPFC predicts the extent of attenuation of negative affect by reappraisal in healthy subjects ([@awaa100-B5]), indicating that normal top-down control of the amygdala can lower anxiety and negative mood. OCD patients show reduced vmPFC-amygdala coupling during appraisal and passive viewing of symptom stimuli ([@awaa100-B35]). In addition, reduced activity in the vmPFC is also associated with impaired recall of fear extinction in OCD ([@awaa100-B47]). The retention of extinction memory is crucial for the success of extinction training, and is therefore also thought to underlie the success of exposure therapy. So the change in top-down control of the vmPFC on the amygdala might mean that DBS restores reappraisal mechanisms and facilitates fear extinction, and can thereby improve mood and anxiety to enable successful cognitive behavioural therapy ([@awaa100-B46]).

The current pathophysiological model for OCD is centred around hyperactivity in cortico-striatal-thalamic loops and does not fully explain negative mood and anxiety. In line with previous suggestions ([@awaa100-B48]), our results suggest that abnormal frontolimbic connectivity needs to be incorporated into that model. In fact, the temporal sequence of symptom changes following DBS shows that improvements in mood and anxiety happen before improvements in obsessions and compulsions ([@awaa100-B17]). The changes in frontolimbic connectivity might therefore precede and enable the changes in frontostriatal circuits that are associated with obsessive-compulsive symptoms ([@awaa100-B21]). The influence of DBS on the frontolimbic circuit may also underlie the restoration of self-confidence, as is typically reported by patients. We recently hypothesized that, in particular, anxiety fuels low self-confidence in OCD, which could be related to insufficient vmPFC control over the amygdala ([@awaa100-B40]).

Just as DBS treatment improves mood and anxiety, its cessation of 1 week was associated with a worsening of symptoms. We previously found that mood and anxiety scores even tend to be higher than before the initiation of treatment ([@awaa100-B17]). This rebound effect can be sudden, even in patients who do not experience a clear anxiolytic effect of DBS ([@awaa100-B37]). Fortunately, the clinical effects are reinstated rapidly once DBS is turned on again ([@awaa100-B14]). These clinical observations indicate that the effects of DBS on the amygdala network may be acute and that DBS has limited effects on neural plasticity.

The frontolimbic network has primarily been implicated in other anxiety disorders and depression ([@awaa100-B61]). VALIC DBS is also beneficial for treatment resistant depression, suggesting that DBS-induced changes in vmPFC-amygdala-insula connectivity might also be important for its clinical effects in major depression ([@awaa100-B7]). At the same time, this implies that vALIC DBS might be beneficial for other treatment-resistant anxiety disorders for which DBS is not yet a treatment option. A case study in a patient with post-traumatic stress disorder suggests that direct amygdala DBS is promising ([@awaa100-B41]), but our results suggests that vALIC stimulation could also be used to target the amygdala network. Besides DBS, similar neural network changes may underlie clinical improvement induced by other treatment options such as pharmacotherapy and psychotherapy, which could be explored in future studies.

We stimulated the patients within the vALIC that consists of two fibre bundles. The anterior thalamic radiation (ATR) connects the thalamus to the prefrontal cortex, and the supero-lateral branch of the medial forebrain bundle (slMFB) connects the ventral tegmental area to the prefrontal cortex. We previously found that stimulation closer to the slMFB is associated with a better clinical outcome, based on tracking of white matter bundles of each patient using diffusion MRI ([@awaa100-B42]). In contrast, another recent study reported that better outcome is associated with stimulation of tracts that presumably overlap with the ATR, based on an average white matter tract model of healthy individuals ([@awaa100-B4]). Furthermore, a recent study reported that another tract that connects the amygdala to the prefrontal cortex runs ventral to the ALIC ([@awaa100-B22]). As all these pathways are integrated at the striatal and amygdala level ([@awaa100-B8]), the contribution of each of these pathways to the DBS effects on the amygdala circuitry we reported here remains unclear, which requires further investigation.

There are a few limitations to our study. First the sample size is small as can be expected for a neuroimaging study with fully implanted DBS electrodes, which previously has only been investigated in several cases ([@awaa100-B52]). The small sample size did not allow us to assess the influence of clinical heterogeneity or concurrent medication use. Second, spectral DCM is a technique that is hard to validate in the absence of known causal network changes; however, it has been shown to be able to recover those changes in synthetic data ([@awaa100-B53]) and was found to be more sensitive to group differences than conventional DCM. Further, a recent study shows that spectral DCM has good inter-subject and inter-session reliability when studying the default mode network ([@awaa100-B1]). Third, a relatively small number of nodes can be used in spectral DCM due to computational reasons, requiring *a priori* specification of regions of interest. We therefore only selected those nodes that had shown DBS-related changes in functional connectivity in the current and a previous study ([@awaa100-B21]). Fourth, in our study we cannot disentangle the effects of DBS on mood or anxiety separately due to the high correlation between them. Further work is needed to see if DBS is affecting one more than the other or if mood and anxiety change concurrently.

In conclusion, our results reveal a neural network model for how vALIC DBS could exert its rapid effects on mood and anxiety, which may enable patients to challenge their obsessive-compulsive symptoms with behavioural therapy. Mood and anxiety symptoms may therefore be more important in OCD than often appreciated, or at least they are critical symptoms targeted by effective vALIC DBS for OCD. In fact, the initial modulation of the frontolimbic circuit may enable later alterations in the frontostriatal circuit, which we found is related to eventual changes in compulsivity ([@awaa100-B21]). Beyond OCD, the frontolimbic network also has an important role in other anxiety disorders and depression ([@awaa100-B32]; [@awaa100-B61]). This suggests that modulation of the vmPFC-amygdala-insula circuit may also have a role in the clinical effects of vALIC DBS in depression ([@awaa100-B7]) and highlights its potential as a novel treatment option for patients with other treatment-resistant anxiety disorders. Future studies may investigate whether other treatment modalities exert their antidepressant and anxiolytic effects through similar neural mechanisms.
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